18新利l|18新利网站

Skip to content Skip to search Skip to footer Taylor Family Institute for Innovative Psychiatric Research Open Menu Back Close Menu Search for: Search Close Search AboutAbout Clinical Trial Partnerships Affiliated Departments Resources ResearchResearch Active Research Progress Our TeamOur Team Leadership Core Investigators Affiliates Join Us News Donate Open Search Changing the landscape of mental health Explore our research Working together to diminish the impact of psychiatric illness The Taylor Family Institute for Innovative Psychiatric Research seeks to eradicate mental illness by exploring and developing new treatments and therapies for psychiatric disorders. Our Progress Since the institute’s inception, our team has developed and tested neurosteroids as neuropsychiatric treatments. Institute work has resulted in successful clinical trials, expansion of research into neuroactive cholesterol metabolites, and other work. Learn about our accomplishments Our Current Studies The Institute continues its work on neurosteroids and focus on depression while also moving into the realm of oxysterols and psychosis. Current studies focus on topics such as subtypes of GABA receptors in drug effects, binding sites on transmitter receptors important for drug actions, brain circuits important for behaviors involved in neuropsychiatric dysfunction, studies of early childhood mood disorders, and more.   Learn about our ongoing research Research training opportunities Students and trainees can work alongside investigators at the Taylor Family Institute and receive formalized training and mentorship through various programs at Washington University School of Medicine. View training programs Our Unique Approach Expertise across disciplines The Institute brings together a broad, innovative network of collaborators dedicated to drug discovery, the development of novel therapeutics, lifestyle interventions and clinical applications. Meet our team Accelerating time to market Our unique industry partnership with Sage Therapeutics promotes opportunities for novel biochemical targets to travel more rapidly down the drug development pipeline and into clinical application. Learn about our process Flexible funding from donors The pipeline from drug discovery to clinical application and treatment requires significant funding, often unavailable from government sources. The Taylor Family and other donors make our work possible. Learn about the institute Taylor Family Institute for Innovative Psychiatric ResearchDepartment of Psychiatry660 S. Euclid Ave.Campus Box 8134St. Louis, MO 63110-1093 ©2024 Washington University in St. Louis   Loading Comments...   Write a Comment... Email (Required) Name (Required) Website